Telix Pharmaceuticals Limited
← Back to TLX Overview

Telix Pharmaceuticals Limited (TLX)

Profitability & Net Margin History

Current Net Margin

-1.17%

Telix Pharmaceuticals Limited currently has a net profit margin of -1.17%. Net margin is a key efficiency ratio that measures what percentage of each dollar of revenue actually results in profit for the company.

Historical Margin Data

Quarterly and annual profitability trends

DateRevenue ($B)Net Income ($B)Net MarginChange (bps)
2025-12-310.62-0.01-1.17%58
2025-06-300.59-0.00-0.59%702
2024-12-310.590.046.43%25
2024-06-300.190.016.18%75
2023-12-310.280.026.93%1342
2023-06-300.22-0.01-6.48%1791
2022-12-310.14-0.03-24.39%27041
2022-06-300.02-0.07-294.80%72944
2021-12-310.00-0.05-1024.24%9308
2021-06-300.00-0.03-1117.32%38005
2020-12-310.00-0.03-737.27%40156
2020-06-300.00-0.02-1138.83%8950
2019-12-310.00-0.02-1049.33%47879
2019-06-300.00-0.01-570.54%386023
2018-12-310.00-0.01-4430.77%
2018-06-30-0.01
2017-12-310.00-0.00-9850.62%
2017-06-30-0.00
2017-01-31-0.00
2016-06-300.00
2015-12-31-0.00
2015-06-30-0.00
2000-09-30-0.00
2000-06-30
2000-01-31
1999-06-30
1999-01-31

* Net margin = (Net Income / Total Revenue) * 100. Based on official SEC filings.